Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes

doi:10.4239/wjd.v16.i2.98423

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (149)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=113

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=30

Feb 15, 2025 (publication date) through Jan 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Feb 15, 2025; 16(2): 98423
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.98423

Table 2 Ki-67 expression among the three groups

Group	Number of patients	Negative (%)	Weakly positive (%)	Moderately positive (%)	Strongly positive (%)	Total positive rate (%)
A	160	21 (13.13)	60 (37.50)	42 (26.25)	37(23.13)	139 (86.87)
B	200	46 (23.00)	107 (53.50)^b	24 (12.00)^b	23 (11.50)^b	154 (77.00)^a
C	60	58 (96.67)	2 (3.33)^b^,^d	0^b^,^d	0^b^,^d	2 (3.33)^b^,^d

^aP < 0.05 vs group A.

^bP < 0.01 vs group A.

^dP < 0.01 vs group B.

Values are presented as the mean ± SD. Group A: Patients with acute ischemic stroke (AIS) and type 2 diabetes mellitus; Group B: Patients with AIS alone; Group C: Patients with benign pulmonary lesions.

Citation: Chen K, Wang G, Hu JC, Zhou YY, Ma HT. Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes. World J Diabetes 2025; 16(2): 98423
URL: https://www.wjgnet.com/1948-9358/full/v16/i2/98423.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i2.98423